Translate AMICOR contents if you like

Saturday, May 16, 2020

Bill Gates: Pandemics

Bill Gates Has Regrets
Bill Gates Has Regrets
Betsy McKay, The Wall Street Journal
Years before the Covid-19 pandemic, the billionaire tried to warn global leaders of the threat from new infectious diseases. Few listened. ‘I feel terrible.’
Read this story now »


Five years ago, Bill Gates warned that the biggest potential killer the world faced wasn’t war, but a pandemic. The billionaire spent hundreds of millions of dollars to find faster ways to develop vaccines and create disease-tracking systems. He urged world leaders to build national defenses against new infectious diseases.
Looking back, Mr. Gates said, “I wish I had done more to call attention to the danger.” The Microsoft Corp. co-founder is now squaring off against the scenario he sought to forestall.
“I feel terrible,” he said in an interview. “The whole point of talking about it was that we could take action and minimize the damage.”
In his second career as philanthropist and co-chair of one of the wealthiest foundations dedicated to global health and American education, Mr. Gates, 64 years old, has put himself at the center of the Covid-19 pandemic that has killed more than 283,000 people and crashed the world economy.
On DefenseGates Foundation direct spending onpandemic preparednessSource: Bill & Melinda Gates Foundation*in West Africa and Democratic Republic of Congo
$305 million100763920Covid-19CEPI (vaccine financing coalition)Ebola*General preparednessZika
The Bill & Melinda Gates Foundation pays for researchers seeking treatments, and it is working with pharmaceutical executives and governments to produce billions of doses of promising vaccines while they are being tested so they can be dispensed as soon as regulators approve them. The foundation has helped reserve space in a manufacturing plant so production of the most effective new medicines can begin quickly.
WSJ NEWSLETTER

What's News

A digest of the day's most important news to watch, delivered to your inbox.

No comments: